Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 55

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 55
---
 of a financial reporting measure that was in excess of the amount that such covered officer would have received taking into account the restated financial results. The clawback policy is available as an exhibit to the 2024 Form 10-K.

Accounting and Tax Effects

The impact of accounting treatment is considered in developing and implementing our compensation programs, including the accounting treatment as it applies to amounts awarded or paid to our executive officers.

The impact of federal tax laws on our compensation programs is also considered, including the deductibility of compensation paid to the named executive officers, as limited by Section 162(m) of the Code. Our compensation program historically had been designed with the intention that compensation paid in various forms may be eligible to qualify for deductibility under Section 162(m) of the Code, but there have been and may be other exceptions for administrative or other reasons. However, the Tax Cuts and Jobs Act of 2017 eliminated the exception under Section 162(m) for performance-based compensation and expanded the number of employees who may be covered by these deductibility limitations, which may have an effect on how we design future compensation programs and may affect the financial statement impact of executive compensation payments.

<div align='center'>44</div>

| REPORT OF THE COMPENSATION AND TALENT DEVELOPMENT COMMITTEE |

The Compensation and Talent Development Committee has reviewed and discussed the Compensation Discussion and Analysis with the members of management of the Company and, based on such review and discussions, the Compensation and Talent Development Committee recommended to the Board that the Compensation Discussion and Analysis be included in the Company’s proxy statement.

| The Compensation and Talent Development Committee |
| Charles R. Kummeth, Committee Chair               |
| Alan L. Bazaar                                    |
| Jason M. Hannon                                   |
| Michael E. Paolucci                               |

<div align='center'>45</div>

| SUMMARY COMPENSATION TABLE |

The following table sets forth the compensation earned by or paid to our named executive officers for each of the last three fiscal years during which the officer was a named executive officer.

| Name and Principal Position(1)                   
 Active Officers as of December 31, 2024:         
 Massimo Calafiore - President and                | Year 
 2024 |     | Salary 
 ($)    | 793,269 |     |     | Bonus 
 ($)   |       — |     |     | Stock  
 Awards 
 ($)(2) | 6,558,979 |     | Option 
 Awards 
 ($)(2) | 2,